- Home
- MNY vs DYAI Comparison
MNY vs DYAI Comparison
Compare MNY & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNY
- DYAI
- Stock Information
- Founded
- MNY 2014
- DYAI 1979
- Country
- MNY Singapore
- DYAI United States
- Employees
- MNY N/A
- DYAI N/A
- Industry
- MNY
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MNY
- DYAI Health Care
- Exchange
- MNY Nasdaq
- DYAI Nasdaq
- Market Cap
- MNY 31.9M
- DYAI 29.6M
- IPO Year
- MNY N/A
- DYAI 2004
- Fundamental
- Price
- MNY $1.08
- DYAI $0.94
- Analyst Decision
- MNY Strong Buy
- DYAI Strong Buy
- Analyst Count
- MNY 1
- DYAI 1
- Target Price
- MNY $4.00
- DYAI $6.00
- AVG Volume (30 Days)
- MNY 187.9K
- DYAI 61.6K
- Earning Date
- MNY 06-13-2025
- DYAI 08-12-2025
- Dividend Yield
- MNY N/A
- DYAI N/A
- EPS Growth
- MNY N/A
- DYAI N/A
- EPS
- MNY N/A
- DYAI N/A
- Revenue
- MNY $71,649,746.00
- DYAI $3,554,344.00
- Revenue This Year
- MNY $31.98
- DYAI $22.56
- Revenue Next Year
- MNY $10.97
- DYAI $30.95
- P/E Ratio
- MNY N/A
- DYAI N/A
- Revenue Growth
- MNY N/A
- DYAI 57.59
- 52 Week Low
- MNY $0.55
- DYAI $0.91
- 52 Week High
- MNY $1.86
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- MNY 72.75
- DYAI 46.80
- Support Level
- MNY $0.99
- DYAI $0.91
- Resistance Level
- MNY $1.10
- DYAI $0.99
- Average True Range (ATR)
- MNY 0.09
- DYAI 0.06
- MACD
- MNY 0.04
- DYAI 0.00
- Stochastic Oscillator
- MNY 95.45
- DYAI 33.40
About MNY MoneyHero Limited
MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services. Geographically it operates in Singapore, Hong Kong, Taiwan, Malaysia and the Philippines.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.